nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—BCHE—diaphragm—amyotrophic lateral sclerosis	0.0459	0.182	CbGeAlD
Perindopril—ACE—forelimb—amyotrophic lateral sclerosis	0.0283	0.112	CbGeAlD
Perindopril—Cardiac murmur—Riluzole—amyotrophic lateral sclerosis	0.0281	0.0398	CcSEcCtD
Perindopril—Nephritis—Riluzole—amyotrophic lateral sclerosis	0.0255	0.0361	CcSEcCtD
Perindopril—ACE—hindlimb—amyotrophic lateral sclerosis	0.0255	0.101	CbGeAlD
Perindopril—ACE—arm—amyotrophic lateral sclerosis	0.0244	0.0966	CbGeAlD
Perindopril—ACE—appendage—amyotrophic lateral sclerosis	0.0219	0.0868	CbGeAlD
Perindopril—ACE—peripheral nervous system—amyotrophic lateral sclerosis	0.0199	0.0789	CbGeAlD
Perindopril—ACE—nerve—amyotrophic lateral sclerosis	0.0155	0.0615	CbGeAlD
Perindopril—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0196	CcSEcCtD
Perindopril—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0196	CcSEcCtD
Perindopril—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0188	CcSEcCtD
Perindopril—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0177	CcSEcCtD
Perindopril—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0153	CcSEcCtD
Perindopril—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00965	0.0137	CcSEcCtD
Perindopril—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00965	0.0137	CcSEcCtD
Perindopril—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0094	0.0133	CcSEcCtD
Perindopril—Gout—Riluzole—amyotrophic lateral sclerosis	0.00934	0.0132	CcSEcCtD
Perindopril—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00928	0.0131	CcSEcCtD
Perindopril—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00883	0.0125	CcSEcCtD
Perindopril—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00862	0.0122	CcSEcCtD
Perindopril—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00842	0.0119	CcSEcCtD
Perindopril—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00828	0.0117	CcSEcCtD
Perindopril—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00788	0.0111	CcSEcCtD
Perindopril—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00764	0.0108	CcSEcCtD
Perindopril—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00742	0.0105	CcSEcCtD
Perindopril—ACE—embryo—amyotrophic lateral sclerosis	0.00727	0.0288	CbGeAlD
Perindopril—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00708	0.01	CcSEcCtD
Perindopril—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00704	0.00996	CcSEcCtD
Perindopril—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00674	0.00953	CcSEcCtD
Perindopril—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00674	0.00953	CcSEcCtD
Perindopril—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00671	0.00949	CcSEcCtD
Perindopril—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00665	0.00941	CcSEcCtD
Perindopril—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00657	0.00929	CcSEcCtD
Perindopril—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00654	0.00925	CcSEcCtD
Perindopril—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00651	0.00921	CcSEcCtD
Perindopril—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00636	0.00899	CcSEcCtD
Perindopril—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00623	0.00881	CcSEcCtD
Perindopril—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00611	0.00864	CcSEcCtD
Perindopril—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00602	0.00851	CcSEcCtD
Perindopril—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00602	0.00851	CcSEcCtD
Perindopril—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.006	0.00848	CcSEcCtD
Perindopril—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00578	0.00818	CcSEcCtD
Perindopril—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00572	0.00809	CcSEcCtD
Perindopril—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00558	0.00789	CcSEcCtD
Perindopril—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00774	CcSEcCtD
Perindopril—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00536	0.00759	CcSEcCtD
Perindopril—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00754	CcSEcCtD
Perindopril—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00526	0.00744	CcSEcCtD
Perindopril—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0052	0.00735	CcSEcCtD
Perindopril—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00512	0.00723	CcSEcCtD
Perindopril—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00505	0.00715	CcSEcCtD
Perindopril—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00713	CcSEcCtD
Perindopril—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00499	0.00706	CcSEcCtD
Perindopril—BCHE—brainstem—amyotrophic lateral sclerosis	0.00492	0.0195	CbGeAlD
Perindopril—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00694	CcSEcCtD
Perindopril—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00481	0.0068	CcSEcCtD
Perindopril—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00478	0.00676	CcSEcCtD
Perindopril—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00672	CcSEcCtD
Perindopril—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00672	CcSEcCtD
Perindopril—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00474	0.00671	CcSEcCtD
Perindopril—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00661	CcSEcCtD
Perindopril—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00658	CcSEcCtD
Perindopril—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00461	0.00652	CcSEcCtD
Perindopril—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.0046	0.00651	CcSEcCtD
Perindopril—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00458	0.00647	CcSEcCtD
Perindopril—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00644	CcSEcCtD
Perindopril—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00446	0.0063	CcSEcCtD
Perindopril—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0044	0.00622	CcSEcCtD
Perindopril—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00621	CcSEcCtD
Perindopril—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00619	CcSEcCtD
Perindopril—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00619	CcSEcCtD
Perindopril—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00616	CcSEcCtD
Perindopril—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00615	CcSEcCtD
Perindopril—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00612	CcSEcCtD
Perindopril—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0061	CcSEcCtD
Perindopril—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00607	CcSEcCtD
Perindopril—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00586	CcSEcCtD
Perindopril—ACE—spinal cord—amyotrophic lateral sclerosis	0.00414	0.0164	CbGeAlD
Perindopril—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00579	CcSEcCtD
Perindopril—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00575	CcSEcCtD
Perindopril—SLC15A2—medulla oblongata—amyotrophic lateral sclerosis	0.00405	0.0161	CbGeAlD
Perindopril—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00562	CcSEcCtD
Perindopril—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00558	CcSEcCtD
Perindopril—Chills—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00556	CcSEcCtD
Perindopril—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00553	CcSEcCtD
Perindopril—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00547	CcSEcCtD
Perindopril—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00543	CcSEcCtD
Perindopril—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00539	CcSEcCtD
Perindopril—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00531	CcSEcCtD
Perindopril—Tension—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00529	CcSEcCtD
Perindopril—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00528	CcSEcCtD
Perindopril—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0037	0.00524	CcSEcCtD
Perindopril—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00521	CcSEcCtD
Perindopril—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00518	CcSEcCtD
Perindopril—SLC15A2—spinal cord—amyotrophic lateral sclerosis	0.00361	0.0143	CbGeAlD
Perindopril—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00505	CcSEcCtD
Perindopril—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00354	0.005	CcSEcCtD
Perindopril—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00498	CcSEcCtD
Perindopril—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00495	CcSEcCtD
Perindopril—ACE—nervous system—amyotrophic lateral sclerosis	0.00349	0.0138	CbGeAlD
Perindopril—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00493	CcSEcCtD
Perindopril—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00486	CcSEcCtD
Perindopril—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.00343	0.0136	CbGeAlD
Perindopril—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00484	CcSEcCtD
Perindopril—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00483	CcSEcCtD
Perindopril—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00483	CcSEcCtD
Perindopril—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00476	CcSEcCtD
Perindopril—ACE—central nervous system—amyotrophic lateral sclerosis	0.00336	0.0133	CbGeAlD
Perindopril—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00474	CcSEcCtD
Perindopril—Cough—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0047	CcSEcCtD
Perindopril—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00465	CcSEcCtD
Perindopril—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00459	CcSEcCtD
Perindopril—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00459	CcSEcCtD
Perindopril—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00459	CcSEcCtD
Perindopril—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00457	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00456	CcSEcCtD
Perindopril—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00453	CcSEcCtD
Perindopril—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00449	CcSEcCtD
Perindopril—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00444	CcSEcCtD
Perindopril—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0044	CcSEcCtD
Perindopril—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0044	CcSEcCtD
Perindopril—Shock—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00433	CcSEcCtD
Perindopril—BCHE—spinal cord—amyotrophic lateral sclerosis	0.00306	0.0121	CbGeAlD
Perindopril—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00431	CcSEcCtD
Perindopril—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00431	CcSEcCtD
Perindopril—SLC15A2—nervous system—amyotrophic lateral sclerosis	0.00304	0.0121	CbGeAlD
Perindopril—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00429	CcSEcCtD
Perindopril—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00427	CcSEcCtD
Perindopril—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00425	CcSEcCtD
Perindopril—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00419	CcSEcCtD
Perindopril—SLC15A2—central nervous system—amyotrophic lateral sclerosis	0.00293	0.0116	CbGeAlD
Perindopril—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00411	CcSEcCtD
Perindopril—SLC15A2—cerebellum—amyotrophic lateral sclerosis	0.00286	0.0114	CbGeAlD
Perindopril—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00401	CcSEcCtD
Perindopril—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00398	CcSEcCtD
Perindopril—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00395	CcSEcCtD
Perindopril—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00392	CcSEcCtD
Perindopril—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00391	CcSEcCtD
Perindopril—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00387	CcSEcCtD
Perindopril—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00382	CcSEcCtD
Perindopril—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00269	0.0038	CcSEcCtD
Perindopril—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00379	CcSEcCtD
Perindopril—ACE—brain—amyotrophic lateral sclerosis	0.00267	0.0106	CbGeAlD
Perindopril—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00376	CcSEcCtD
Perindopril—Pain—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00376	CcSEcCtD
Perindopril—BCHE—nervous system—amyotrophic lateral sclerosis	0.00258	0.0102	CbGeAlD
Perindopril—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00363	CcSEcCtD
Perindopril—ABCB1—embryo—amyotrophic lateral sclerosis	0.00256	0.0101	CbGeAlD
Perindopril—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0036	CcSEcCtD
Perindopril—BCHE—central nervous system—amyotrophic lateral sclerosis	0.00248	0.00984	CbGeAlD
Perindopril—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0035	CcSEcCtD
Perindopril—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00348	CcSEcCtD
Perindopril—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00348	CcSEcCtD
Perindopril—BCHE—cerebellum—amyotrophic lateral sclerosis	0.00242	0.00962	CbGeAlD
Perindopril—SLC15A2—brain—amyotrophic lateral sclerosis	0.00233	0.00922	CbGeAlD
Perindopril—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00316	CcSEcCtD
Perindopril—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00311	CcSEcCtD
Perindopril—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00301	CcSEcCtD
Perindopril—BCHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.00213	0.0523	CbGpPWpGaD
Perindopril—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00291	CcSEcCtD
Perindopril—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0028	CcSEcCtD
Perindopril—BCHE—brain—amyotrophic lateral sclerosis	0.00197	0.00781	CbGeAlD
Perindopril—Rash—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00277	CcSEcCtD
Perindopril—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00277	CcSEcCtD
Perindopril—Headache—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00276	CcSEcCtD
Perindopril—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00261	CcSEcCtD
Perindopril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00182	0.0448	CbGpPWpGaD
Perindopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.00169	0.0416	CbGpPWpGaD
Perindopril—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00163	0.00648	CbGeAlD
Perindopril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00155	0.0381	CbGpPWpGaD
Perindopril—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00146	0.00578	CbGeAlD
Perindopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.00144	0.0353	CbGpPWpGaD
Perindopril—ABCB1—nervous system—amyotrophic lateral sclerosis	0.00123	0.00487	CbGeAlD
Perindopril—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00118	0.00469	CbGeAlD
Perindopril—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00116	0.00458	CbGeAlD
Perindopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00107	0.0264	CbGpPWpGaD
Perindopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.000997	0.0245	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000959	0.0236	CbGpPWpGaD
Perindopril—ABCB1—brain—amyotrophic lateral sclerosis	0.000939	0.00372	CbGeAlD
Perindopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.000913	0.0224	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.000892	0.0219	CbGpPWpGaD
Perindopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.000847	0.0208	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.000838	0.0206	CbGpPWpGaD
Perindopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000825	0.0203	CbGpPWpGaD
Perindopril—BCHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.000824	0.0202	CbGpPWpGaD
Perindopril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.000781	0.0192	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000727	0.0179	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000665	0.0163	CbGpPWpGaD
Perindopril—BCHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.000624	0.0153	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.000575	0.0141	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000551	0.0135	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.000537	0.0132	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00048	0.0118	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000454	0.0111	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000445	0.0109	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.000436	0.0107	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000427	0.0105	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000408	0.01	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000394	0.00968	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000385	0.00946	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000382	0.00938	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000381	0.00935	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000379	0.0093	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000378	0.00929	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000364	0.00893	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000351	0.00863	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000348	0.00855	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000338	0.00829	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000338	0.00829	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000327	0.00804	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000325	0.00798	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000324	0.00795	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000324	0.00795	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000309	0.00759	CbGpPWpGaD
Perindopril—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.000308	0.00757	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000302	0.00742	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000292	0.00717	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000292	0.00716	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000288	0.00709	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000287	0.00705	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00027	0.00663	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000267	0.00656	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000267	0.00655	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000254	0.00625	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000248	0.00609	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000248	0.00609	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000244	0.00599	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.00024	0.00589	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000226	0.00556	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000221	0.00543	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000221	0.00543	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.000215	0.00529	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000215	0.00528	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000207	0.00509	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000207	0.00509	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000207	0.00509	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000204	0.00501	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000192	0.00473	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000192	0.00473	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000185	0.00454	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000185	0.00454	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000182	0.00447	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000172	0.00421	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000164	0.00403	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000153	0.00376	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00015	0.00369	CbGpPWpGaD
Perindopril—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00015	0.00369	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000145	0.00356	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000143	0.0035	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00014	0.00344	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000138	0.0034	CbGpPWpGaD
Perindopril—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000138	0.00338	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00013	0.0032	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00013	0.0032	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000128	0.00314	CbGpPWpGaD
Perindopril—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00012	0.00295	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000119	0.00292	CbGpPWpGaD
Perindopril—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000109	0.00267	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000101	0.00249	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000101	0.00247	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	9.63e-05	0.00236	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	8.58e-05	0.00211	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	8.48e-05	0.00208	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	8.41e-05	0.00207	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	8.24e-05	0.00202	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	8.09e-05	0.00199	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.65e-05	0.00188	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	7.6e-05	0.00187	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.34e-05	0.0018	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.34e-05	0.0018	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	7.28e-05	0.00179	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.93e-05	0.0017	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	6.71e-05	0.00165	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.51e-05	0.0016	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.51e-05	0.0016	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	6.24e-05	0.00153	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.24e-05	0.00153	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	5.87e-05	0.00144	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.8e-05	0.00142	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.7e-05	0.0014	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	5.5e-05	0.00135	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	5.31e-05	0.0013	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	4.56e-05	0.00112	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.23e-05	0.00104	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	4.07e-05	0.000999	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.02e-05	0.000988	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.9e-05	0.000959	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	3.71e-05	0.000911	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.59e-05	0.000883	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.36e-05	0.000824	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.08e-05	0.000758	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.05e-05	0.000748	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.72e-05	0.000667	CbGpPWpGaD
Perindopril—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	2.54e-05	0.000623	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.74e-05	0.000427	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.64e-05	0.000402	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.5e-05	0.00037	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.24e-05	0.000304	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.48e-06	0.000208	CbGpPWpGaD
